
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1946-1973
Open Access | Times Cited: 23
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1946-1973
Open Access | Times Cited: 23
Showing 23 citing articles:
Tumor-microenvironment-activatable organic phototheranostic agents for cancer therapy
Shuang Zeng, Zhihan Guo, Yifu Hao, et al.
Coordination Chemistry Reviews (2024) Vol. 509, pp. 215786-215786
Closed Access | Times Cited: 25
Shuang Zeng, Zhihan Guo, Yifu Hao, et al.
Coordination Chemistry Reviews (2024) Vol. 509, pp. 215786-215786
Closed Access | Times Cited: 25
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma
Xiyu Song, Yumeng Zhu, Wenwen Geng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010183-e010183
Open Access | Times Cited: 1
Xiyu Song, Yumeng Zhu, Wenwen Geng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010183-e010183
Open Access | Times Cited: 1
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Integrated Analysis of Bulk RNA Sequencing, eQTL , GWAS , and Single‐Cell RNA Sequencing Reveals Key Genes in Hepatocellular Carcinoma
Mingkai Gong, Xian Zhao, Qiuxuan Li, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Mingkai Gong, Xian Zhao, Qiuxuan Li, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma
Wenjing Wu, Jianchao Wang, Fuqing Chen, et al.
Molecular Oncology (2025)
Open Access
Wenjing Wu, Jianchao Wang, Fuqing Chen, et al.
Molecular Oncology (2025)
Open Access
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma
Deyu Kong, Yiping Zhang, Linxin Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Deyu Kong, Yiping Zhang, Linxin Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma
Zhengwei Zhang, Xiaoning Chen, Yapeng Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1564-1583
Open Access | Times Cited: 3
Zhengwei Zhang, Xiaoning Chen, Yapeng Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1564-1583
Open Access | Times Cited: 3
The improving strategies and applications of nanotechnology-based drugs in hepatocellular carcinoma treatment
Xiangyang Ren, Danyang Su, Doudou Shi, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Xiangyang Ren, Danyang Su, Doudou Shi, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Stromal interaction molecule 1/microtubule‐associated protein 1A/1B‐light chain 3B complex induces metastasis of hepatocellular carcinoma by promoting autophagy
Jingchun Wang, Qichao Xie, Lei Wu, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 2
Jingchun Wang, Qichao Xie, Lei Wu, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 2
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence
Xian‐Yang Qin, Yohei Shirakami, Masao Honda, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 582-594
Open Access | Times Cited: 2
Xian‐Yang Qin, Yohei Shirakami, Masao Honda, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 582-594
Open Access | Times Cited: 2
Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq
Zhengwei Zhang, Yuying Li, Zhen Quan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Zhengwei Zhang, Yuying Li, Zhen Quan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Hydrogel Local Drug Delivery Systems for Postsurgical Management of Tumors: Status Quo and Perspectives
Ziqiao Zhong, Lu Gan, Ziyi Feng, et al.
Materials Today Bio (2024) Vol. 29, pp. 101308-101308
Open Access | Times Cited: 1
Ziqiao Zhong, Lu Gan, Ziyi Feng, et al.
Materials Today Bio (2024) Vol. 29, pp. 101308-101308
Open Access | Times Cited: 1
The regulatory role of autophagy between TAMs and tumor cells
Min Hu, Jiao‐Xiu Fan, Ziyue He, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Open Access
Min Hu, Jiao‐Xiu Fan, Ziyue He, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Open Access
Tumor budding is a meaningful prognostic marker in patients with hepatocellular carcinoma after curative hepatectomy
Kaibo Yang, Kunjin Wu, Zitong Lei, et al.
Portal hypertension & cirrhosis (2024) Vol. 3, Iss. 2, pp. 86-95
Open Access
Kaibo Yang, Kunjin Wu, Zitong Lei, et al.
Portal hypertension & cirrhosis (2024) Vol. 3, Iss. 2, pp. 86-95
Open Access
Exploring the Role of KIR3DL2 on NK Cells in Hepatocellular Carcinoma and Its Potential Prognostic Implications
Jie Zhu, Anli Jin, Baishen Pan, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110637-110637
Closed Access
Jie Zhu, Anli Jin, Baishen Pan, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110637-110637
Closed Access
Dual-Synergistic Nanomodulator Alleviates Exosomal PD-L1 Expression Enabling Exhausted Cytotoxic T Lymphocytes Rejuvenation for Potentiated iRFA-Treated Hepatocellular Carcinoma Immunotherapy
Xiaoqi Zhu, Tinghua Li, Qin Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32818-32833
Closed Access
Xiaoqi Zhu, Tinghua Li, Qin Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32818-32833
Closed Access
Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
Q H Fan, Pengcheng Wei, Delin Ma, et al.
Surgery Open Science (2024) Vol. 23, pp. 16-23
Open Access
Q H Fan, Pengcheng Wei, Delin Ma, et al.
Surgery Open Science (2024) Vol. 23, pp. 16-23
Open Access
DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study
Bolun Zhang, Jun-Shuai Xue, Bowen Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Bolun Zhang, Jun-Shuai Xue, Bowen Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Mesoporous cerium oxide nanoenzyme for Efficacious impeding tumor and metastasis via Conferring resistance to anoikis
Yunhao Wang, Lei Ding, Juan Feng, et al.
Biomaterials (2024) Vol. 314, pp. 122876-122876
Closed Access
Yunhao Wang, Lei Ding, Juan Feng, et al.
Biomaterials (2024) Vol. 314, pp. 122876-122876
Closed Access
Predictors for 30-day mortality in hepatocellular carcinoma patients undergoing liver resection
Erik Prabowo, Neni Susilaningsih, Catharina Suharti, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e1001-e1001
Open Access
Erik Prabowo, Neni Susilaningsih, Catharina Suharti, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e1001-e1001
Open Access
Notch Pathway Deactivation Sensitizes Breast Cancer Stem Cells toward Chemotherapy Using NIR Light-Responsive Nanoparticles
Yuwei Liu, Yang Zhou, Yunong Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 17, Iss. 1, pp. 430-444
Closed Access
Yuwei Liu, Yang Zhou, Yunong Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 17, Iss. 1, pp. 430-444
Closed Access